Susquehanna Fundamental Investments’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Susquehanna Fundamental Investments’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-17	Closed	-$104K	–	1791
2021 Q1	$104K	Sell	17 -35	-67%	-$254K	﹤0.01%	1464
2020 Q4	$294K	Sell	52 -20	-28%	-$126K	0.01%	1269
2020 Q3	$428K	Hold	72	–	–	0.01%	933
2020 Q2	$446K	Buy	+72	New	+$488K	0.02%	643

Other funds holding YARW

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Susquehanna Fundamental Investments's YARW Position: Q2 2021 in Review

Susquehanna Fundamental Investments sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q2 2021, closing a stake of 17 shares — an estimated $104K sold.

Susquehanna Fundamental Investments first reported a position in YARW in Q2 2020 and held it in 4 quarters. The position peaked at $446K in Q2 2020. 63 funds tracked by Wall St. Rank hold YARW as of Q2 2021.

Susquehanna Fundamental Investments reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Susquehanna Fundamental Investments sold 17 Yarrow Bioscience, Inc. Common Stock shares in Q2 2021, an estimated $104K.
Susquehanna Fundamental Investments first reported a position in Yarrow Bioscience, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
Susquehanna Fundamental Investments's Yarrow Bioscience, Inc. Common Stock position peaked at $446K in Q2 2020.
63 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q2 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2021, filed 11 Aug 2021.